Delivery Order SPE2DR25D2206-SPE2DR26F9DV9
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ondansetron HCL 8 mg tablets (500-count units) with a ceiling value of $4,385.35. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 13, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $6,713.22. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) with a contract value of $2,164.46. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, under a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $17,165.18 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a completion date of December 15, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,018.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award involves no set-aside designation, indicating the contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count packaging) with a ceiling value of $2,155.21. This firm fixed-price delivery order, awarded on November 13, 2025, with ultimate completion by November 14, 2025, represents a child contract action under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. Performance will be executed...
- The Defense Logistics Agency awarded a $12,625.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packages) on November 13, 2025, with completion targeted for November 14, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $3,117.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packaging) with a completion date of September 24, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, where the company is headquartered. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $15,617.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units), with an ultimate completion date of November 12, 2025. This competitive award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026....